Eiger BioPharmaceuticals, Inc.
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS
Last updated:
Abstract:
In one aspect, methods of treating non-alcoholic steatohepatitis (NASH) or preventing or delaying the progression of non-alcoholic fatty liver disease (NAFLD) to NASH are provided. In some embodiments, the method comprises administering a therapeutically effective amount of ubenimex.
Status:
Application
Type:
Utility
Filling date:
4 Feb 2020
Issue date:
30 Jul 2020